Noa Gordon

Trajectories of Injectable Cancer Drug Costs After Launch in the United States

Noa Gordon, Salomon M. Stemmer, Dan Greenberg et al. · Journal of Clinical Oncology · 2017 · 102 citations

Injectable Cancer Drug, Price Trajectories, Cancer Management +20

A Phamacoeconomic Analysis of Personalized Dosing vs Fixed Dosing of Pembrolizumab in Firstline PD-L1-Positive Non–Small Cell Lung Cancer

Daniel A. Goldstein, Noa Gordon, Michal Davidescu et al. · JNCI Journal of the National Cancer Institute · 2017 · 99 citations · Full text

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Michal Sarfaty, Moshe Leshno, Noa Gordon et al. · European Urology · 2017 · 66 citations

Urology, Genitourinary Cancer, Medicine +3

Cost-effectiveness of Pembrolizumab in Second-line Advanced Bladder Cancer

Michal Sarfaty, Peter Hall, Kelvin Chan et al. · European Urology · 2018 · 66 citations · Full text

Oncology, Urology, Medicine +1

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma

Assaf Moore, Michal Cohen‐Naftaly, Anna Tobar et al. · Radiation Oncology · 2017 · 65 citations · Full text